These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23899990)

  • 41. "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases.
    He H; Trpkov K; Martinek P; Isikci OT; Maggi-Galuzzi C; Alaghehbandan R; Gill AJ; Tretiakova M; Lopez JI; Williamson SR; Montiel DP; Sperga M; Comperat E; Brimo F; Yilmaz A; Pivovarcikova K; Michalova K; Slouka D; Prochazkova K; Hora M; Bonert M; Michal M; Hes O
    Virchows Arch; 2018 Dec; 473(6):725-738. PubMed ID: 30232607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: Does it have a real benefit?
    Asi T; Tuncali MÇ; Tuncel M; Alkanat NEİ; Hazir B; Kösemehmetoğlu K; Baydar DE; Akdoğan B
    Urol Oncol; 2020 Dec; 38(12):937.e11-937.e17. PubMed ID: 32859460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China.
    Guo Q; Liu N; Wang F; Guo Y; Yang B; Cao Z; Wang Y; Wang Y; Zhang W; Huang Q; Zhao W; Liu C; Qu T; Li L; Cao L; Ren D; Meng B; Qi L; Wang C; Cao W
    Virchows Arch; 2021 Mar; 478(3):449-458. PubMed ID: 32918598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
    Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
    Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of rapid kV-switching dual energy CT in renal tumor characterization.
    Çamlıdağ İ; Nural MS; Danacı M; Özden E
    Abdom Radiol (NY); 2019 May; 44(5):1841-1849. PubMed ID: 30637472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.
    Williamson SR; Gadde R; Trpkov K; Hirsch MS; Srigley JR; Reuter VE; Cheng L; Kunju LP; Barod R; Rogers CG; Delahunt B; Hes O; Eble JN; Zhou M; McKenney JK; Martignoni G; Fleming S; Grignon DJ; Moch H; Gupta NS
    Hum Pathol; 2017 May; 63():149-156. PubMed ID: 28315424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
    An J; Park CK; Kim M; Joo JW; Cho NH
    Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute histologic effects of temperature-based radiofrequency ablation on renal tumor pathologic interpretation.
    Margulis V; Matsumoto ED; Lindberg G; Tunc L; Taylor G; Sagalowsky AI; Cadeddu JA
    Urology; 2004 Oct; 64(4):660-3. PubMed ID: 15491694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient and nonradiographic tumor characteristics predicting lipid-poor angiomyolipoma in small renal masses: Introducing the BEARS index.
    Bauman TM; Potretzke AM; Wright AJ; Vetter JM; Potretzke TA; Figenshau RS
    Investig Clin Urol; 2017 Jul; 58(4):235-240. PubMed ID: 28681032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Do we need an updated classification of oncocytic renal tumors? : Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities.
    Hes O; Trpkov K
    Mod Pathol; 2022 Sep; 35(9):1140-1150. PubMed ID: 35273336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients.
    Schachter LR; Cookson MS; Chang SS; Smith JA; Dietrich MS; Jayaram G; Herrell SD
    J Endourol; 2007 Aug; 21(8):819-23. PubMed ID: 17867935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
    Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
    Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
    Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
    Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study.
    Breda A; Treat EG; Haft-Candell L; Leppert JT; Harper JD; Said J; Raman S; Smith RB; Belldegrun AS; Schulam PG
    BJU Int; 2010 Apr; 105(7):940-5. PubMed ID: 19888984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
    Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
    Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinicopathological features of low-grade oncocytic renal tumor (CD117-negative, cytokeratin 7-positive): report of seven cases].
    Xie B; Cheng LC; Yin GL; Liu BA; Hu ZL; Tong K
    Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):719-725. PubMed ID: 35922161
    [No Abstract]   [Full Text] [Related]  

  • 58. Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management.
    Nazzani S; Zaborra C; Biasoni D; Catanzaro M; Macchi A; Stagni S; Tesone A; Torelli T; Lanocita R; Cascella T; Morosi C; Spreafico C; Colecchia M; Marchianò A; Montanari E; Salvioni R; Nicolai N
    Scand J Urol; 2022; 56(5-6):367-372. PubMed ID: 35766193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of gender and size on the pathology of small renal mass.
    Hsieh PF; Chang CH; Huang CP; Chen CC; Chen KL; Chang SS; Yeh CC; Chen WC; Chou CL; Wu HC
    Kaohsiung J Med Sci; 2012 Jul; 28(7):369-72. PubMed ID: 22726898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sporadic renal hybrid oncocytic/chromophobe tumor in a young man: A case report.
    Hou B; Liang C
    Medicine (Baltimore); 2019 Aug; 98(33):e16641. PubMed ID: 31415358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.